The use of biomarkers to diagnose the ecological impact of pollutants in Mediterranean rivers

Um assunto que requer atenção é a avaliação ecológica da qualidade da água de ecossistemas de água doce. Uma abordagem que surge como promissora é a biomonitorização baseada em biomarcadores, porque pode avaliar a saúde dos organismos e obter sinais de alerta precoce acerca dos riscos ambientais. Até agora, porém, o uso de biomarcadores em espécies de invertebrados, para diagnosticar danos ecológicos nos rios, é escasso. Por essa razão, existe uma necessidade urgente de desenvolver biomarcadores nas principais espécies de macroinvertebrados dos ecossistemas fluviais que são alvo de estudo. Esta tese tem como objectivo averiguar se as respostas in situ, aliadas aos biomarcadores, podem ser um método viável para avaliar os danos ecológicos de contaminantes em ecossistemas de água doce. Numa primeira fase, os biomarcadores foram usados para averiguar os mecanismos fisiológicos de adaptação genética de clones de Daphnia magna ao pesticida organofosforado fenitrothion. Numa segunda fase, os biomarcadores foram usados como ferramentas de diagnóstico de poluição em zonas ribeirinhas. Estes estudos foram realizados com três espécies-chave de macroinvertebrados: Daphnia magna, Corbicula fluminea e Hydropsyche exocellata, nos rios Besós e Llobregat e no Delta do rio Ebro (NE Espanha). Além disso, foram realizados com animais capturados nos rios, ou com ensaios de transplantes, e foram complementados com índices biológicos de macroinvertebrados e análises químicas da água e dos animais. Como os contaminantes químicos têm vários modos toxicológicos de acção e, portanto, afectam várias respostas bioquímicas dos organismos, foram analisados nas três espécies um conjunto de biomarcadores pertencentes a diferentes vias metabólicas. A abordagem experimental indica que o uso combinado de biomarcadores e outras medidas, tais como índices biológicos e testes in situ, contribui para diagnosticar os efeitos prejudiciais de contaminantes nas comunidades ribeirinhas.

Concentration of tumor biomarkers using aqueous biphasic systems

According to the World Health Organization, around 8.2 million people die each year with cancer. Most patients do not perform routine diagnoses and the symptoms, in most situations, occur when the patient is already at an advanced stage of the disease, consequently resulting in a high cancer mortality. Currently, prostate cancer is the second leading cause of death among males worldwide. In Portugal, this is the most diagnosed type of cancer and the third that causes more deaths. Taking into account that there is no cure for advanced stages of prostate cancer, the main strategy comprises an early diagnosis to increase the successful rate of the treatment. The prostate specific antigen (PSA) is an important biomarker of prostate cancer that can be detected in biological fluids, including blood, urine and semen. However, the commercial kits available are addressed for blood samples and the commonly used analytical methods for their detection and quantification requires specialized staff, specific equipment and extensive sample processing, resulting in an expensive process. Thus, the aim of this MSc thesis consisted on the development of a simple, efficient and less expensive method for the extraction and concentration of PSA from urine samples using aqueous biphasic systems (ABS) composed of ionic liquids. Initially, the phase diagrams of a set of aqueous biphasic systems composed of an organic salt and ionic liquids were determined. Then, their ability to extract PSA was ascertained. The obtained results reveal that in the tested systems the prostate specific antigen is completely extracted to the ionic-liquid-rich phase in a single step. Subsequently, the applicability of the investigated ABS for the concentration of PSA was addressed, either from aqueous solutions or urine samples. The low concentration of this biomarker in urine (clinically significant below 150 ng/mL) usually hinders its detection by conventional analytical techniques. The obtained results showed that it is possible to extract and concentrate PSA, up to 250 times in a single-step, so that it can be identified and quantified using less expensive techniques.

Concentration of tumor biomarkers using aqueous biphasic systems

According to the World Health Organization, around 8.2 million people die each year with cancer. Most patients do not perform routine diagnoses and the symptoms, in most situations, occur when the patient is already at an advanced stage of the disease, consequently resulting in a high cancer mortality. Currently, prostate cancer is the second leading cause of death among males worldwide. In Portugal, this is the most diagnosed type of cancer and the third that causes more deaths. Taking into account that there is no cure for advanced stages of prostate cancer, the main strategy comprises an early diagnosis to increase the successful rate of the treatment. The prostate specific antigen (PSA) is an important biomarker of prostate cancer that can be detected in biological fluids, including blood, urine and semen. However, the commercial kits available are addressed for blood samples and the commonly used analytical methods for their detection and quantification requires specialized staff, specific equipment and extensive sample processing, resulting in an expensive process. Thus, the aim of this MSc thesis consisted on the development of a simple, efficient and less expensive method for the extraction and concentration of PSA from urine samples using aqueous biphasic systems (ABS) composed of ionic liquids. Initially, the phase diagrams of a set of aqueous biphasic systems composed of an organic salt and ionic liquids were determined. Then, their ability to extract PSA was ascertained. The obtained results reveal that in the tested systems the prostate specific antigen is completely extracted to the ionic-liquid-rich phase in a single step. Subsequently, the applicability of the investigated ABS for the concentration of PSA was addressed, either from aqueous solutions or urine samples. The low concentration of this biomarker in urine (clinically significant below 150 ng/mL) usually hinders its detection by conventional analytical techniques. The obtained results showed that it is possible to extract and concentrate PSA, up to 250 times in a single-step, so that it can be identified and quantified using less expensive techniques.